Cheung NK, Dyer MA. Neuroblastoma: developmental biology, cancer genomics and immunotherapy. Nature reviews. 2013;13(6):397–411.
CAS
PubMed
PubMed Central
Google Scholar
Matthay KK, Reynolds CP, Seeger RC, Shimada H, Adkins ES, Haas-Kogan D, Gerbing RB, London WB, Villablanca JG. Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study. J Clin Oncol. 2009;27(7):1007–13.
Article
CAS
PubMed
PubMed Central
Google Scholar
Modak S, Cheung NKV. Neuroblastoma: therapeutic strategies for a clinical enigma. Cancer Treat Rev. 2010;36(4):307–17.
Article
CAS
PubMed
Google Scholar
Ribatti D. The chick embryo chorioallantoic membrane in the study of tumor angiogenesis. Romanian J Morphol Embryol. 2008;49(2):131–5.
CAS
Google Scholar
Ribatti D, Gualandris A, Bastaki M, Vacca A, Iurlaro M, Roncali L, Presta M. New model for the study of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane: the gelatin sponge/chorioallantoic membrane assay. J Vasc Res. 1997;34(6):455–63.
Article
CAS
PubMed
Google Scholar
Cimpean AM, Ribatti D, Raica M. The chick embryo chorioallantoic membrane as a model to study tumor metastasis. Angiogenesis. 2008;11(4):311–9.
Article
PubMed
Google Scholar
Herrmann A, Rice M, Levy R, Pizer BL, Losty PD, Moss D, See V. Cellular memory of hypoxia elicits neuroblastoma metastasis and enables invasion by non-aggressive neighbouring cells. Oncogene. 2015;4:e138.
Article
CAS
Google Scholar
Lokman NA, Elder AS, Ricciardelli C, Oehler MK. Chick Chorioallantoic membrane (CAM) assay as an in vivo model to study the effect of newly identified molecules on ovarian cancer invasion and metastasis. Int J Mol Sci. 2012;13(8):9959–70.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kim Y, Williams KC, Gavin CT, Jardine E, Chambers AF, Leong HS. Quantification of cancer cell extravasation in vivo. Nat Protoc. 2016;11(5):937–48.
Article
CAS
PubMed
Google Scholar
Rytelewski M, Buensuceso A, Leong HS, Deroo BJ, Chambers AF, Koropatnick J. Evaluating the effectiveness of cancer drug sensitization in vitro and in vivo. J Vis Exp. 2015;96: e52388. https://doi.org/10.3791/52388
Sathe A, Koshy N, Schmid SC, Thalgott M, Schwarzenbock SM, Krause BJ, Holm PS, Gschwend JE, Retz M, Nawroth R. CDK4/6 inhibition controls proliferation of bladder cancer and transcription of RB1. J Urol. 2016;195(3):771–9.
Article
CAS
PubMed
Google Scholar
Eggert A, Ikegaki N, Liu XG, Brodeur GM. Prognostic and biological role of neurotrophin-receptor TrkA and TrkB in neuroblastoma. Klin Padiatr. 2000;212(4):200–5.
Article
CAS
PubMed
Google Scholar
Monclair T, Brodeur GM, Ambros PF, Brisse HJ, Cecchetto G, Holmes K, Kaneko M, London WB, Matthay KK, Nuchtern JG, et al. The international neuroblastoma risk group (INRG) staging system: an INRG task force report. J Clin Oncol. 2009;27(2):298–303.
Article
PubMed
PubMed Central
Google Scholar
Blumrich A, Zapatka M, Brueckner LM, Zheglo D, Schwab M, Savelyeva L. The FRA2C common fragile site maps to the borders of MYCN amplicons in neuroblastoma and is associated with gross chromosomal rearrangements in different cancers. Hum Mol Genet. 2011;20(8):1488–501.
Article
CAS
PubMed
Google Scholar
Carter R, Mullassery D, See V, Theocharatos S, Pizer B, Losty PD, Jesudason E, Moss DJ. Exploitation of chick embryo environments to reprogram MYCN-amplified neuroblastoma cells to a benign phenotype, lacking detectable MYCN expression. Oncogene. 2012;1:e24.
Article
CAS
Google Scholar
Armstrong PB, Quigley JP, Sidebottom E. Transepithelial invasion and intramesenchymal infiltration of the chick embryo chorioallantois by tumor cell lines. Cancer Res. 1982;42(5):1826–37.
CAS
PubMed
Google Scholar
Herrmann A, Moss D, See V. The Chorioallantoic membrane of the Chick embryo to assess tumor formation and metastasis. Tumor Angiogenesis Assays: Methods and Protocols. 2016;1464:97–105.
Article
CAS
Google Scholar
Thiele CJ, Reynolds CP, Israel MA. Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma. Nature. 1985;313(6001):404–6.
Article
CAS
PubMed
Google Scholar
Clark O, Daga S, Stoker AW. Tyrosine phosphatase inhibitors combined with retinoic acid can enhance differentiation of neuroblastoma cells and trigger ERK- and AKT-dependent, p53-independent senescence. Cancer Lett. 2013;328(1):44–54.
Article
CAS
PubMed
Google Scholar
Guglielmi L, Cinnella C, Nardella M, Maresca G, Valentini A, Mercanti D, Felsani A, D'Agnano I. MYCN gene expression is required for the onset of the differentiation programme in neuroblastoma cells. Cell Death Dis. 2014;5:e1081.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sung PJ, Boulos N, Tilby MJ, Andrews WD, Newbold RF, Tweddle DA, Lunec J. Identification and characterisation of STMN4 and ROBO2 gene involvement in neuroblastoma cell differentiation. Cancer Lett. 2013;328:168–75.
Otto T, Horn S, Brockmann M, Eilers U, Schuttrumpf L, Popov N, Kenney AM, Schulte JH, Beijersbergen R, Christiansen H, et al. Stabilization of N-Myc is a critical function of aurora a in human neuroblastoma. Cancer Cell. 2009;15(1):67–78.
Article
CAS
PubMed
Google Scholar
Brockmann M, Poon E, Berry T, Carstensen A, Deubzer HE, Rycak L, Jamin Y, Thway K, Robinson SP, Roels F, et al. Small molecule inhibitors of aurora-a induce proteasomal degradation of N-myc in childhood neuroblastoma. Cancer Cell. 2013;24(1):75–89.
Article
CAS
PubMed
PubMed Central
Google Scholar
Maris JM, Morton CL, Gorlick R, Kolb EA, Lock R, Carol H, Keir ST, Reynolds CP, Kang MH, Wu JR, et al. Initial testing of the aurora kinase a inhibitor MLN8237 by the pediatric preclinical testing program (PPTP). Pediatr Blood Cancer. 2010;55(1):26–34.
PubMed
PubMed Central
Google Scholar
Balke M, Neumann A, Kersting C, Agelopoulos K, Gebert C, Gosheger G, Buerger H, Hagedorn M. Morphologic characterization of osteosarcoma growth on the chick chorioallantoic membrane. BMC Res Notes. 2010;3:58.
Article
PubMed
PubMed Central
Google Scholar
Shalinsky DR, Bischoff ED, Gregory ML, Gottardis MM, Hayes JS, Lamph WW, Heyman RA, Shirley MA, Cooke TA, Davies PJ, et al. Retinoid-induced suppression of squamous cell differentiation in human oral squamous cell carcinoma xenografts (line 1483) in athymic nude mice. Cancer Res. 1995;55(14):3183–91.
CAS
PubMed
Google Scholar
Wyatt RD, Howarth B Jr. Effect of dimethyl sulfoxide on embryonic survival and subsequent chick performance. Poult Sci. 1976;55(2):579–82.
Article
CAS
PubMed
Google Scholar
Russell WMS, Burch RL: The principles of humane experimental technique: Wheathampstead: universities federation for Anim Welf,; 1992.
Kalirai H, Shahidipour H, Moss DJ, Coupland SE, Luyten G. Use of the Chick embryo model in uveal melanoma. Ocul Oncol Pathol. 2015;1(3):133–40.
Article
PubMed
PubMed Central
Google Scholar
Sugiura Y, Shimada H, Seeger RC, Laug WE, DeClerck YA. Matrix metalloproteinases-2 and -9 are expressed in human neuroblastoma: contribution of stromal cells to their production and correlation with metastasis. Cancer Res. 1998;58(10):2209–16.
CAS
PubMed
Google Scholar
Vargas A, Zeisser-Labouebe M, Lange N, Gurny R, Delie F. The chick embryo and its chorioallantoic membrane (CAM) for the in vivo evaluation of drug delivery systems. Adv Drug Deliv Rev. 2007;59(11):1162–76.
Article
CAS
PubMed
Google Scholar
Borrill Mather G: The Chick embryo; A new drug delivery model for Neuroblastoma. MPhil. University of Liverpool; 2014.
Kampmann E, Mey J. Retinoic acid enhances Erk phosphorylation in the chick retina. Neurosci Lett. 2007;426(1):18–22.
Article
CAS
PubMed
Google Scholar
Chen F, Zhuang X, Lin L, Yu P, Wang Y, Shi Y, Hu G, Sun Y. New horizons in tumor microenvironment biology: challenges and opportunities. BMC Med. 2015;13:45.
Article
PubMed
PubMed Central
Google Scholar
Veal GJ, Errington J, Rowbotham SE, Illingworth NA, Malik G, Cole M, Daly AK, Pearson AD, Boddy AV. Adaptive dosing approaches to the individualization of 13-cis-retinoic acid (isotretinoin) treatment for children with high-risk neuroblastoma. Clin Cancer Res. 2013;19(2):469–79.
Article
CAS
PubMed
Google Scholar
Zage PE, Zeng L, Palla S, Fang W, Nilsson MB, Heymach JV, Zweidler-McKay PA. A novel therapeutic combination for neuroblastoma: the vascular endothelial growth factor receptor/epidermal growth factor receptor/rearranged during transfection inhibitor vandetanib with 13-cis-retinoic acid. Cancer. 2010;116(10):2465–75.
CAS
PubMed
Google Scholar